technetium has been researched along with Hyperlipoproteinemia Type II in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heikkilä, JI; Kervinen, K; Kesäniemi, YA; Savolainen, MJ | 1 |
| Aguilar Cortes, E; Berdun Cheliz, MA; Bernat Badia, A; Mor Julve, E; Playan Uson, J | 1 |
| Agapov, II; Fuki, IV; Konovalov, GA; Kukharchuk, VV; Repin, VS; Sergienko, VB | 1 |
3 other study(ies) available for technetium and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Lovastatin enhances hepatic uptake of low density lipoprotein in humans.
Topics: Adult; Apolipoproteins B; Cholesterol, LDL; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Iodine Radioisotopes; Lipoproteins, LDL; Liver; Lovastatin; Lung; Male; Middle Aged; Myocardium; Technetium | 1993 |
[Thyroid hemiagenesis].
Topics: Adult; Humans; Hyperlipoproteinemia Type II; Male; Radionuclide Imaging; Technetium; Thyroid Gland; Ultrasonography | 1990 |
Effect of plasmapheresis on the liver uptake of ApoB-lipoproteins labeled with technetium-99m.
Topics: Adult; Apolipoproteins B; Arteriosclerosis; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, VLDL; Liver; Male; Plasmapheresis; Radionuclide Imaging; Technetium | 1989 |